Chemomab Therapeutics Ltd Files For Mixed Shelf Of Up To $200M
Portfolio Pulse from Benzinga Newsdesk
Chemomab Therapeutics Ltd has filed for a mixed shelf of up to $200 million, according to a SEC filing.
October 16, 2023 | 8:28 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Chemomab Therapeutics Ltd's filing for a mixed shelf of up to $200 million could potentially dilute existing shares.
The filing for a mixed shelf of up to $200 million by Chemomab Therapeutics Ltd could lead to dilution of existing shares if the company decides to issue new shares. This could potentially lead to a decrease in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100